http://www.newsday.com/news/health/ny-d ... -headlines
Chondroitin Deficiency Found in Pet Products
By Charles Choi
Charles Choi is a freelance writer.
November 4, 2003
When it comes to chow supplements touted as aids for a pet's ailing joints,
a new report finds some contain none of a particularly expensive therapeutic
ingredient they are advertised to contain.
White Plains-based ConsumerLab.com, an independent supplement testing firm,
revealed two pet supplements tested had no chondroitin, an organic compound
clinical studies suggest may help prevent the breakdown of joint cartilage.
"Three years ago, we found the majority of products containing chondroitin
for human use were short on that ingredient," ConsumerLab.com president Dr.
Tod Cooperman said. "The situation has improved for humans, but for pet
owners, the situation seems much worse. They should be extremely concerned
about getting ripped off."
The research team came across these results as part of a larger study
examining human and pet supplements used to treat osteoarthritis. About 30
million Americans have this often-painful ailment, where the cushioning
cartilage between bones wears away.
The investigators focused on products claiming to contain glucosamine,
chondroitin and MSM, substances found naturally in the body. Supplements
with these ingredients generated $790 million in U.S. sales last year.
A one-month supply of chondroitin-glucosamine combination pills for humans
can cost $40. For pets, 350 grams of chondroitin-glucosamine powder can cost
$55, which lasts from 50 to 175 days, depending on the size of the animal.
MSM, or methylsulfonylmethane, is a sulfur compound marketed for joint pain.
Glucosamine is usually extracted from crab, lobster or shrimp shells, and is
a kind of amino sugar research suggests promotes the formation and repair of
cartilage. Chondroitin is typically harvested from cow cartilage, and costs
about 10 times as much as glucosamine. In veterinary medicine, glucosamine
and chondroitin are commonly used in combination to treat degenerative joint
disease, typically in older cats and dogs as well as in horses.
The research team looked at 49 products, of which six are for pets. Of
these, 45 contained the advertised levels of ingredients. Two products for
human use contained 18 percent and 85 percent, respectively. "Most shocking
was that no chondroitin sulfate could be detected in two pet supplements
despite each displaying a 'guaranteed analysis' showing a significant amount
of chondroitin sulfate," the report notes. Chondroitin is almost always
found with sulfate to make it more stable, Cooperman said.
Shawn Madere, chief executive of Paris, Ky.-based Martingale Pharm, defended
his company's product against ConsumerLab.com's allegation that it contained
no chondroitin.
"It was verified and validated by Sanipure Labs, which is one of the most
respected testing companies out there," Madere said. He added testing
companies often get different results because of different testing methods.
Cooperman responded, saying, "We use what's now the approved method in the
industry. It's the same method we used on all the dozens of the other
products containing chondroitin. When we retested it, we even used other
methods just to be sure. We're fairly secure and certain with our methods."
Irena Jacek, a marketing official at Windmill Health Products in West
Caldwell, N.J., one of the two companies cited for low chondroitin levels in
human supplements, said her company was refraining from comment until it saw
the final report. "Consumer Lab's a wonderful company," Jacek said.
The FDA is responsible for the safety and labeling of pet food and pet food
supplements.
"When the FDA identifies significant safety concerns with a particular
product, we take enforcement action. If the agency does not believe that
there are significant safety concerns, we generally try to educate
manufacturers about what they should be doing and consumers about what they
should be looking for in products. As far as dietary supplement-like
products for animals are concerned, buyer beware is a good principle to
practice," FDA official Kimberly Rawlings said.
Charles Choi is a freelance writer.
Newsday, Inc